CryoLife Company Profile (NYSE:CRY)

About CryoLife (NYSE:CRY)

CryoLife logoCryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:CRY
  • CUSIP: 22890310
  • Web: www.cryolife.com
Capitalization:
  • Market Cap: $638.82 million
  • Outstanding Shares: 33,446,000
Average Prices:
  • 50 Day Moving Avg: $19.21
  • 200 Day Moving Avg: $17.97
  • 52 Week Range: $14.02 - $20.30
P/E:
  • Trailing P/E Ratio: 57.58
  • Foreward P/E Ratio: 46.34
  • P/E Growth: 1.48
Sales & Book Value:
  • Annual Revenue: $183.16 million
  • Price / Sales: 3.47
  • Book Value: $6.56 per share
  • Price / Book: 2.90
Profitability:
  • EBIDTA: $23.56 million
  • Net Margins: 6.16%
  • Return on Equity: 7.41%
  • Return on Assets: 4.95%
Debt:
  • Debt-to-Equity Ratio: 0.30%
  • Current Ratio: 5.91%
  • Quick Ratio: 4.88%
Misc:
  • Average Volume: 114,281 shs.
  • Beta: 0.97
  • Short Ratio: 4.16
 

Frequently Asked Questions for CryoLife (NYSE:CRY)

What is CryoLife's stock symbol?

CryoLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

How were CryoLife's earnings last quarter?

CryoLife, Inc. (NYSE:CRY) posted its quarterly earnings results on Monday, July, 24th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.02. The firm had revenue of $47.80 million for the quarter, compared to analyst estimates of $47.02 million. CryoLife had a return on equity of 7.41% and a net margin of 6.16%. CryoLife's quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.13 earnings per share. View CryoLife's Earnings History.

When will CryoLife make its next earnings announcement?

CryoLife is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for CryoLife.

What guidance has CryoLife issued on next quarter's earnings?

CryoLife issued an update on its FY17 earnings guidance on Monday, July, 24th. The company provided EPS guidance of $40-0.43 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.43. The company issued revenue guidance of $188-192 million, compared to the consensus revenue estimate of $189.31 million.

Where is CryoLife's stock going? Where will CryoLife's stock price be in 2017?

3 analysts have issued 12 month price targets for CryoLife's stock. Their forecasts range from $20.00 to $23.50. On average, they expect CryoLife's share price to reach $22.33 in the next twelve months. View Analyst Ratings for CryoLife.

Who are some of CryoLife's key competitors?

Who are CryoLife's key executives?

CryoLife's management team includes the folowing people:

  • James Patrick Mackin, Chairman of the Board, President, Chief Executive Officer
  • D. Ashley Lee CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President
  • James M McDermid, Chief Human Resource Officer
  • John Davis, Senior Vice President - Global Sales and Marketing
  • William Matthews, Senior Vice President - Operations, Quality, and Regulatory
  • Amy D. Horton CPA, Chief Accounting Officer
  • Jean F. Holloway, Chief Compliance Officer, Vice President, General Counsel, Secretary
  • Scott B. Capps, Vice President - Clinical Research
  • David C. Gale Ph.D., Vice President - Research & Development
  • James Bullock, Director

Who owns CryoLife stock?

CryoLife's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Capital Research Global Investors (8.54%), Dimensional Fund Advisors LP (5.86%), Vanguard Group Inc. (4.96%), Macquarie Group Ltd. (4.15%), Northern Trust Corp (3.50%) and State Street Corp (2.27%). Company insiders that own CryoLife stock include Amy Horton, C Elkins Ronald, David Ashley Lee, James Benson, James P Mackin, Ronald D Mccall and Scott B Capps. View Institutional Ownership Trends for CryoLife.

Who sold CryoLife stock? Who is selling CryoLife stock?

CryoLife's stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Goldman Sachs Group Inc., Royal Bank of Canada, Alliancebernstein L.P., Candriam Luxembourg S.C.A., TIAA CREF Investment Management LLC, California State Teachers Retirement System and Public Sector Pension investment Board. Company insiders that have sold CryoLife stock in the last year include Amy Horton and Scott B Capps. View Insider Buying and Selling for CryoLife.

Who bought CryoLife stock? Who is buying CryoLife stock?

CryoLife's stock was acquired by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Macquarie Group Ltd., Dimensional Fund Advisors LP, Vanguard Group Inc., Thomson Horstmann & Bryant Inc., Northern Trust Corp, Marshall Wace North America L.P. and Parametric Portfolio Associates LLC. View Insider Buying and Selling for CryoLife.

How do I buy CryoLife stock?

Shares of CryoLife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CryoLife's stock price today?

One share of CryoLife stock can currently be purchased for approximately $19.00.


MarketBeat Community Rating for CryoLife (NYSE CRY)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about CryoLife and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CryoLife (NYSE:CRY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.33 (17.54% upside)

Analysts' Ratings History for CryoLife (NYSE:CRY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/28/2017Northland SecuritiesReiterated RatingBuy$23.50LowView Rating Details
2/17/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$20.00N/AView Rating Details
1/23/2017Canaccord GenuityReiterated RatingBuy$23.50N/AView Rating Details
7/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00N/AView Rating Details
6/15/2016Lake Street CapitalInitiated CoverageBuy$15.00N/AView Rating Details
(Data available from 8/18/2015 forward)

Earnings

Earnings History for CryoLife (NYSE:CRY)
Earnings by Quarter for CryoLife (NYSE:CRY)
Earnings History by Quarter for CryoLife (NYSE CRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$0.11N/AView Earnings Details
7/24/2017Q2 2017$0.10$0.12$47.02 million$47.80 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.04$0.09$44.64 million$45.10 millionViewN/AView Earnings Details
2/15/2017Q416$0.09$0.12$46.92 million$45.00 millionViewListenView Earnings Details
10/26/2016Q316$0.05$0.13$44.90 million$45.30 millionViewListenView Earnings Details
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/15/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CryoLife (NYSE:CRY)
2017 EPS Consensus Estimate: $0.28
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.04$0.06$0.05
Q2 20172$0.07$0.07$0.07
Q3 20172$0.06$0.07$0.07
Q4 20172$0.09$0.10$0.10
Q1 20181$0.07$0.07$0.07
Q2 20181$0.10$0.10$0.10
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for CryoLife (NYSE:CRY)
Most Recent Dividend:12/18/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CryoLife (NYSE:CRY)

Dividend History by Quarter for CryoLife (NYSE CRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/22/2015quarterly$0.031.22%12/9/201512/11/201512/18/2015
7/22/2015quarterly$0.031.07%9/9/20159/11/20159/18/2015
5/21/2015quarterly$0.031.08%6/10/20156/12/20156/19/2015
2/13/2015quarterly$0.031.12%3/11/20153/13/20153/20/2015
10/23/2014quarterly$0.031.14%12/10/201412/12/201412/19/2014
7/30/2014quarterly$0.031.22%9/10/20149/12/20149/19/2014
5/22/2014quarterly$0.031.38%6/11/20146/13/20146/20/2014
2/19/2014quarterly$0.031.17%3/12/20143/14/20143/21/2014
11/21/2013quarterly$0.031.05%12/11/201312/13/201312/20/2013
8/21/2013quarterly$0.031.72%9/11/20139/13/20139/20/2013
5/28/2013quarterly$0.031.75%6/12/20136/14/20136/21/2013
2/13/2013quarterly$0.031.61%3/12/20133/14/20133/21/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CryoLife (NYSE:CRY)
Insider Ownership Percentage: 6.00%
Institutional Ownership Percentage: 69.22%
Insider Trades by Quarter for CryoLife (NYSE:CRY)
Institutional Ownership by Quarter for CryoLife (NYSE:CRY)
Insider Trades by Quarter for CryoLife (NYSE:CRY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/27/2017Amy HortonVPSell9,577$20.00$191,540.00View SEC Filing  
2/22/2017Scott B CappsVPSell11,083$16.40$181,761.20View SEC Filing  
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.00View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.00View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.00View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.00View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.35View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.35View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.00View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.10View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.00View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.00View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.00View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.00View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.00View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for CryoLife (NYSE:CRY)
Latest Headlines for CryoLife (NYSE:CRY)
Source:
DateHeadline
americanbankingnews.com logoZacks Investment Research Upgrades CryoLife, Inc. (NYSE:CRY) to Hold
www.americanbankingnews.com - August 14 at 7:56 PM
finance.yahoo.com logoETFs with exposure to CryoLife, Inc. : August 14, 2017
finance.yahoo.com - August 14 at 5:56 PM
finance.yahoo.com logoETFs with exposure to CryoLife, Inc. : August 4, 2017
finance.yahoo.com - August 4 at 12:00 AM
americanbankingnews.com logoZacks Investment Research Lowers CryoLife, Inc. (CRY) to Sell
www.americanbankingnews.com - August 2 at 9:34 PM
finance.yahoo.com logoCryoLife to Present at 37th Annual Canaccord Genuity Growth Conference
finance.yahoo.com - August 2 at 6:23 PM
americanbankingnews.com logoCryoLife, Inc. to Post FY2017 Earnings of $0.31 Per Share, First Analysis Forecasts (NYSE:CRY)
www.americanbankingnews.com - August 2 at 10:38 AM
finance.yahoo.com logoEcolab (ECL) Beats Earnings and Revenue Estimates in Q2
finance.yahoo.com - August 1 at 6:16 PM
americanbankingnews.com logoBrokers Offer Predictions for CryoLife, Inc.'s Q3 2017 Earnings (NYSE:CRY)
www.americanbankingnews.com - August 1 at 8:02 AM
finance.yahoo.com logoCryoLife, Inc. breached its 50 day moving average in a Bearish Manner : CRY-US : July 28, 2017
finance.yahoo.com - July 29 at 4:52 PM
finance.yahoo.com logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q2, 2017 By the Numbers : July 26, 2017
finance.yahoo.com - July 26 at 6:07 PM
finance.yahoo.com logoEdited Transcript of CRY earnings conference call or presentation 25-Jul-17 12:00pm GMT
finance.yahoo.com - July 25 at 10:40 PM
finance.yahoo.com logoInvestor Network: CryoLife, Inc. to Host Earnings Call
finance.yahoo.com - July 25 at 5:34 PM
finance.yahoo.com logoCryoLife posts 2Q profit
finance.yahoo.com - July 24 at 10:17 PM
americanbankingnews.com logoCryoLife, Inc. (NYSE:CRY) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - July 24 at 9:14 PM
americanbankingnews.com logoCryoLife, Inc. (NYSE:CRY) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - July 24 at 6:50 PM
americanbankingnews.com logoCryoLife, Inc. (CRY) Updates FY17 Earnings Guidance
www.americanbankingnews.com - July 24 at 5:25 PM
finance.yahoo.com logoCryoLife Reports Second Quarter 2017 Financial Results
finance.yahoo.com - July 24 at 5:13 PM
finance.yahoo.com logoStryker Poised on Solid Product Portfolio and Acquisitions
finance.yahoo.com - July 18 at 7:04 PM
americanbankingnews.com logoCryoLife, Inc. (NYSE:CRY) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - July 17 at 8:52 AM
zacks.com logoMcKesson (MCK) Poised on Improving Generic and Brand Market
www.zacks.com - July 13 at 6:47 PM
finance.yahoo.com logoFresenius Medical (FMS) Well Poised on Growth Strategy 2020
finance.yahoo.com - July 12 at 6:15 PM
finance.yahoo.com logoMasimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked
finance.yahoo.com - July 12 at 6:15 PM
zacks.com logoAmerisourceBergen's PharMEDium Slows Down, Competition Rife
www.zacks.com - July 11 at 11:41 PM
marketwatch.com logoHeart Valve Devices Market 13.35% CAGR by 2021 With TAVR and TMVR Says a Research Report Available at ReportsnReports
www.marketwatch.com - July 11 at 11:41 PM
finance.yahoo.com logoAmerisourceBergen's PharMEDium Slows Down, Competition Rife
finance.yahoo.com - July 11 at 6:39 PM
finance.yahoo.com logoCryoLife Announces Release Date and Teleconference Call Details for 2017 Second Quarter Financial Results
finance.yahoo.com - July 10 at 5:31 PM
americanbankingnews.com logoAmy Horton Sells 9,577 Shares of CryoLife, Inc. (CRY) Stock
www.americanbankingnews.com - June 29 at 10:32 AM
nasdaq.com logoCryoLife Hits a 52-Week High: What's Driving the Stock?
www.nasdaq.com - June 28 at 5:28 PM
finance.yahoo.com logoVarian Rides on Oncology and Proton Therapy Businesses
finance.yahoo.com - June 28 at 5:28 PM
finance.yahoo.com logoCryoLife Hits a 52-Week High: What's Driving the Stock?
finance.yahoo.com - June 28 at 5:28 PM
finance.yahoo.com logoQuintiles' (Q) OCE Software to Simplify Commercial Functions
finance.yahoo.com - June 27 at 4:49 PM
finance.yahoo.com logoETFs with exposure to CryoLife, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 5:20 PM
finance.yahoo.com logoLuminex (LMNX) Banks on Portfolio Strength, View Impressive
finance.yahoo.com - June 22 at 10:41 AM
americanbankingnews.com logoCryolife Inc (CRY) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - June 8 at 7:12 PM
americanbankingnews.com logoCryolife Inc (CRY) Forecasted to Earn Q1 2018 Earnings of $0.07 Per Share
www.americanbankingnews.com - June 7 at 9:14 AM
finance.yahoo.com logoETFs with exposure to CryoLife, Inc. : June 6, 2017
finance.yahoo.com - June 6 at 4:44 PM
americanbankingnews.com logoFirst Analysis Weighs in on Cryolife Inc's Q2 2017 Earnings (CRY)
www.americanbankingnews.com - June 6 at 7:08 AM
marketwatch.com logoProsthetic Heart Valve/Artificial Heart Valve Market Worth 8.86 Billion USD by 2022
www.marketwatch.com - June 5 at 12:02 PM
americanbankingnews.com logoCryolife Inc (CRY) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 29 at 11:08 PM
finance.yahoo.com logoETFs with exposure to CryoLife, Inc. : May 22, 2017
finance.yahoo.com - May 22 at 4:20 PM
finance.yahoo.com logoC. R. Bard, Inc. (BCR)
finance.yahoo.com - May 14 at 4:36 PM
finance.yahoo.com logoETFs with exposure to CryoLife, Inc. : May 8, 2017
finance.yahoo.com - May 8 at 9:23 PM
americanbankingnews.com logoCryolife (CRY) Receives Daily News Impact Rating of 0.03
www.americanbankingnews.com - May 3 at 3:05 PM
americanbankingnews.com logoCryolife Inc (CRY) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 3 at 12:34 AM
finance.yahoo.com logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 4:27 PM
americanbankingnews.com logoCryolife (CRY) Receives News Sentiment Score of 0.32
www.americanbankingnews.com - April 29 at 9:35 PM
finance.yahoo.com logoCryoLife, Inc. – Value Analysis (NYSE:CRY) : April 28, 2017
finance.yahoo.com - April 28 at 5:29 PM
americanbankingnews.com logoCryolife Inc (CRY) Earns "Buy" Rating from Northland Securities
www.americanbankingnews.com - April 28 at 2:58 PM
finance.yahoo.com logoCryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : April 27, 2017
finance.yahoo.com - April 28 at 3:06 AM
finance.yahoo.com logoEdited Transcript of CRY earnings conference call or presentation 27-Apr-17 12:00pm GMT
finance.yahoo.com - April 28 at 3:06 AM

Social

Chart

CryoLife (CRY) Chart for Friday, August, 18, 2017

This page was last updated on 8/18/2017 by MarketBeat.com Staff